AL-MAIDAN CLINIC FOR ORAL HEALTH SERVICES CO.

Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C)

MIDANStocksBoursa KuwaitHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q3 2026Dec 31, 2025	Q2 2026Sep 30, 2025	Q1 2026Jun 30, 2025	Q4 2025Mar 31, 2025
Market & Price
Market Capitalization	168.08M	165.85M	155.72M	147.83M	161.39M
Market Cap Growth	+18.6%	+2.8%	-3.4%	+1.1%	+74.0%
Enterprise Value	119.10M	114.18M	107.63M	96.28M	111.57M
Last Close Price	0.83	0.82	0.77	0.72	0.78
Valuation Multiples
PE Ratio	25.36	25.02	22.82	17.64	—
PS Ratio	2.65	2.61	2.46	2.18	2.24
PB Ratio	1.88	1.85	1.75	1.64	1.83
P/TBV Ratio	1.88	1.86	1.76	1.65	1.83
P/FCF Ratio	23.24	—	17.73	19.34	21.83
P/OCF Ratio	12.45	13.92	16.14	16.61	18.12
EV/Sales Ratio	1.88	1.80	1.70	1.42	1.55
EV/EBITDA Ratio	17.77	16.59	13.47	11.83	—
EV/EBIT Ratio	31.85	25.16	18.99	16.49	—
EV/FCF Ratio	16.47	—	12.25	12.59	15.09
Leverage & Capital
Debt / Equity Ratio	0.01	0.01	0.01	0.06	0.02
Debt / EBITDA Ratio	0.16	0.15	0.10	0.52	5.79
Debt / FCF Ratio	0.14	—	0.13	0.76	0.23
Net Debt / Equity Ratio	-0.55	-0.55	-0.58	-0.54	-0.59
Net Debt / EBITDA Ratio	-8.32	-7.13	-6.48	-5.92	-5.38
Net Debt / FCF Ratio	-6.79	-8.69	-5.90	-6.31	-6.99
Efficiency & Liquidity
Asset Turnover	0.51	0.48	0.49	0.48	0.54
Inventory Turnover	17.08	15.77	15.29	16.52	24.64
Quick Ratio	2.36	2.36	2.48	2.17	2.61
Current Ratio	2.44	2.44	2.56	2.24	2.70
Returns & Yields
Return on Equity (ROE)	+8.4%	+13.8%	+13.9%	-6.6%	+10.1%
Return on Assets (ROA)	+1.8%	+4.2%	+3.9%	-1.3%	+4.3%
Return on Invested Capital (ROIC)	+2.3%	+5.6%	+5.2%	-1.8%	+6.3%
Return on Capital Employed (ROCE)	+3.8%	+4.9%	+6.1%	+6.2%	+7.9%
Earnings Yield	+3.9%	+4.0%	+4.4%	+5.7%	+5.7%
FCF Yield	+4.3%	+3.4%	+5.6%	+5.2%	+4.6%
Dividend Yield	+1.8%	—	—	—	+1.9%
Payout Ratio	+45.8%	—	+98.4%	+0.1%	—
Buyback Yield / Dilution	-1.9%	0.0%	—	—	-8.1%
Total Shareholder Return	-0.1%	0.0%	—	—	-6.2%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q3 2026Dec 31, 2025	Q2 2026Sep 30, 2025	Q1 2026Jun 30, 2025	Q4 2025Mar 31, 2025
Market & Price
Market Capitalization	168.08M	165.85M	155.72M	147.83M	161.39M
Market Cap Growth	+18.6%	+2.8%	-3.4%	+1.1%	+74.0%
Enterprise Value	119.10M	114.18M	107.63M	96.28M	111.57M
Last Close Price	0.83	0.82	0.77	0.72	0.78
Valuation Multiples
PE Ratio	25.36	25.02	22.82	17.64	—
PS Ratio	2.65	2.61	2.46	2.18	2.24
PB Ratio	1.88	1.85	1.75	1.64	1.83
P/TBV Ratio	1.88	1.86	1.76	1.65	1.83
P/FCF Ratio	23.24	—	17.73	19.34	21.83
P/OCF Ratio	12.45	13.92	16.14	16.61	18.12
EV/Sales Ratio	1.88	1.80	1.70	1.42	1.55
EV/EBITDA Ratio	17.77	16.59	13.47	11.83	—
EV/EBIT Ratio	31.85	25.16	18.99	16.49	—
EV/FCF Ratio	16.47	—	12.25	12.59	15.09
Leverage & Capital
Debt / Equity Ratio	0.01	0.01	0.01	0.06	0.02
Debt / EBITDA Ratio	0.16	0.15	0.10	0.52	5.79
Debt / FCF Ratio	0.14	—	0.13	0.76	0.23
Net Debt / Equity Ratio	-0.55	-0.55	-0.58	-0.54	-0.59
Net Debt / EBITDA Ratio	-8.32	-7.13	-6.48	-5.92	-5.38
Net Debt / FCF Ratio	-6.79	-8.69	-5.90	-6.31	-6.99
Efficiency & Liquidity
Asset Turnover	0.51	0.48	0.49	0.48	0.54
Inventory Turnover	17.08	15.77	15.29	16.52	24.64
Quick Ratio	2.36	2.36	2.48	2.17	2.61
Current Ratio	2.44	2.44	2.56	2.24	2.70
Returns & Yields
Return on Equity (ROE)	+8.4%	+13.8%	+13.9%	-6.6%	+10.1%
Return on Assets (ROA)	+1.8%	+4.2%	+3.9%	-1.3%	+4.3%
Return on Invested Capital (ROIC)	+2.3%	+5.6%	+5.2%	-1.8%	+6.3%
Return on Capital Employed (ROCE)	+3.8%	+4.9%	+6.1%	+6.2%	+7.9%
Earnings Yield	+3.9%	+4.0%	+4.4%	+5.7%	+5.7%
FCF Yield	+4.3%	+3.4%	+5.6%	+5.2%	+4.6%
Dividend Yield	+1.8%	—	—	—	+1.9%
Payout Ratio	+45.8%	—	+98.4%	+0.1%	—
Buyback Yield / Dilution	-1.9%	0.0%	—	—	-8.1%
Total Shareholder Return	-0.1%	0.0%	—	—	-6.2%